Keywords: roche, gi, cancer, therapy, good, folfox, swiss

Roche GI cancer therapy as good as FOLFOX

Article | 26 January 2009

Print This

Swiss drug major Roche presented overall survival results from a 14-month follow-up of the Phase III NO16966 study confirming that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in